People on the new weight loss drug have lost up to 2.5 stone
The results of an 18-month trial of tirzepatide, a weekly injection medication, has seen participants shed up to 15.7 percent of their body weight - a loss of 15.6kg or 2.5 stone. Patients given a placebo comparatively lost an average of 3.2kg.
Eli Lilly published the results of a phase three trial on Thursday that evaluated 938 adult participants with obesity or overweight and type 2 diabetes. The news comes a month after the NHS approved semaglutide, a weight loss drug also known as Ozempic and Wegovy. Both tirzepatide and semaglutide mimic a hormone called GLP-1 that suppresses the appetite.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
People of State Pension age could see mobility element in new benefit next yearPension Age Disability Payment will provide financial support for more than 125,000 pensioners living in Scotland.
Lire la suite »
'Misunderstood' dog still looking for a new home despite video reaching one million peopleAn emotional video appeal to find Hilbrae's lonely Loki a forever home has gone viral.
Lire la suite »
Town's new discount shop that people have been 'waiting for'The new shop opened for the first time on Thursday (April 27).
Lire la suite »
Rihanna reveals exciting new role, new music plus pregnancy update: photosRihanna rocks oversized denim cape for surprise appearance on stage at Cinemacon during third trimester!
Lire la suite »
The Rise of Luar: How Raul Lopez Built New York’s New It-BrandIn the latest issue of AnOther Magazine, Luar’s Raul Lopez talks about his New York community, leaving Hood By Air, and the power dressing of the women who raised him
Lire la suite »
Exclusive: Vulnerable People 'Abandoned' As Energy Bill Help Falls Hundreds Of Pounds ShortNew research reveals millions of people will be hit by increased costs.
Lire la suite »